Clinical Assessment
The purpose of the service is to manufacture and preserve an individual’s microbiota under controlled conditions should it be considered appropriate for future clinical use.
Before collection, each patient undergoes an individual clinical assessment to determine whether autologous microbiota preservation is appropriate. The assessment may include:
- Medical history
- Current health status
- Medication review
- Lifestyle questionnaire
- Laboratory investigations where clinically indicated
The collected material is manufactured, processed and stored by TML.science, an MHRA-regulated manufacturer of faecal microbiota products operating under appropriate pharmaceutical quality systems.Collection is normally undertaken when the individual is considered to be in good general health.
Manufactured by TML.science
The manufacturing process is carried out through structured, validated procedures designed to support quality, traceability and product integrity.
The manufacturing process includes:
- Receipt and identification
- Quality assessment
- Controlled processing
- Manufacture under validated procedures
- Storage
- Quality documentation and traceability
Quality Management
Each stage is performed in accordance with established quality management procedures.
Long-Term Storage
Following manufacture, autologous microbiota preparations are stored in monitored storage facilities maintained by TML.science.
- Continuous temperature monitoring
- Validated storage conditions
- Full chain of custody
- Batch documentation
- Quality assurance oversight
Some individuals may wish to preserve their microbiota before circumstances that could alter the gut microbiome, such as:
- Individuals wishing to preserve their microbiome while in good health
- People anticipating medical treatments that may affect gut microbial diversity
- Individuals interested in proactive microbiome preservation strategies
- Patients seeking future options for microbiome restoration, where clinically appropriate
Suitability is determined on an individual basis following clinical assessment.
The decision regarding any future use of preserved material would always be made by an appropriately qualified clinician, taking account of the patient’s clinical circumstances and the regulatory framework applicable at that time.
Why Choose Taymount Clinic?
Taymount Clinic has more than a decade of experience in microbiome-focused healthcare and provides regulated clinical services through its CQC-registered facility.
Patients receive
- Individual clinical assessment
- Experienced microbiome clinicians
- Personalised clinical support
- Comprehensive patient screening
- Robust clinical governance
- CQC-regulated healthcare services
Integrated Pathway
Manufacture, quality control and long-term storage are provided by TML.science, an experienced specialist manufacturer of faecal microbiota products operating under MHRA regulatory oversight.
Together, Taymount Clinic and TML.science provide an integrated pathway for the clinical assessment, manufacture and preservation of autologous microbiota products while maintaining high standards of quality, traceability and patient safety.
Important Information
Autologous microbiota preservation is a collection and storage service. Preservation of microbiota does not guarantee that the stored material will be suitable for future clinical use, nor does it guarantee that future treatment will be clinically indicated or available.
Any future use of preserved material would be subject to an appropriate clinical assessment and the regulatory requirements in force at that time.